GMP Platform Advantages
Product Details
GMP GENPower? NLS-Cas9 Nuclease is a recombinant Streptococcus pyogenes Cas9 protein purified from Escherichia coli for CRISPR-based genome editing. The introduction of nuclear localization signals (NLS) can help Cas9 enter the nucleus, increasing the chance of genomic DNA cleavage.
Vial Specification
2R (13 mm neck finish)
MANUFACTURING SPECIFICATIONS
Product Details
| Application | ? Genetic modification of cells and gene therapy drugs (T cell, hematopoietic stem cell) ? High specificity detection of pathogens |
| Concentration | 10 mg/mL |
| Purity | >95% as determined by SDS-PAGE. >95% as determined by SEC-HPLC. |
| Host Cell Protein | ≤10 ng/mg of protein tested by ELISA. |
| Host Cell DNA | ≤1 ng/mg of protein tested by qPCR. |
| Sterility | Sterility testing was performed using the membrane filtration method in compliance with USP <71> and Ph. Eur. 2.6.1. |
| Endotoxin | Less than 10 EU/mg, tested by the LAL method in compliance with USP <85> and Ph. Eur. 2.6.14. |
| Formulation | Supplied as 0.2 μm filtered solution in 20 mM Tris, 300 mM NaCl, 0.1 mM EDTA, 1 mM TCEP, pH7.5. Contact us for customized product form or formulation. |
| Shipping | This product is supplied and shipped with dry ice, please inquire the shipping cost. |
Storage
ACROBIOSYSTEMS - LEGAL NOTICES FOR GMP GRADE PRODUCTS
ACRO has the right, at its sole discretion, to modify, add or remove any terms herein without notice to Purchaser and/or End User. Any changes to these terms are effective immediately following the updating of such changes on ACRO’s website or published specifications or product-related documents.